ZBH

SELL

Zimmer Biomet Holdings, Inc.

Healthcare · Rank #350 · Analyzed Apr 20, 2026

$94.78

Current Price

$151.86

Intrinsic Value

+156.7%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 156.7%

Fair Value Range

Low$50.79

Base (IV)$151.86

High$243.34

Entry Points

Conservative$50.79

Moderate$101.32

Aggressive$151.86

Quality & Moat Breakdown

Return on Equity5.6% → 0/1.0

Debt LevelD/E 62 → 0/1.0

Revenue QualityGrowth 15.6%, margin Δ-29.4% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins8.6% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.